CODEXIS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.26 USD | -7.39% |
|
-3.55% | +6.89% |
Presentation Operator MessageOperator (Operator)Welcome to the Codexis Strategic Update Confer...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Codexis, Inc. is an enzyme engineering company. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high performance enzymes and other classes of proteins. It utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) therapeutics through an enzymatic route. It also uses the CodeEvolver platform technology to develop enzymes for the synthesis of nucleic acids, such as DNA/RNA, including enzymes utilized in its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Calendar
2024-06-11
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
3.26
USD
Average target price
7.125
USD
Spread / Average Target
+118.56%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.89% | 230M | |
| +51.85% | 57.87B | |
| +41.76% | 40.25B | |
| -5.25% | 39.94B | |
| -5.16% | 28.54B | |
| +12.79% | 26.4B | |
| -20.18% | 19.33B | |
| +30.88% | 12.4B | |
| +0.61% | 12.23B | |
| +25.06% | 12.2B |
- Stock Market
- Equities
- CDXS Stock
- News Codexis, Inc.
- Transcript : Codexis, Inc. - Special Call
